Homrich & Berg’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$12.7M Sell
78,898
-1,948
-2% -$332K 0.29% 27
2021
Q2
$13.3M Buy
80,846
+12,660
+19% +$2.1M 0.31% 25
2021
Q1
$11.2M Buy
68,186
+4,367
+7% +$707K 0.29% 31
2020
Q4
$10M Buy
63,819
+3,026
+5% +$447K 0.29% 32
2020
Q3
$9.05M Sell
60,793
-431
-0.7% -$63.8K 0.31% 28
2020
Q2
$8.61M Buy
61,224
+8,812
+17% +$1.28M 0.35% 26
2020
Q1
$6.87M Sell
52,412
-1,139
-2% -$162K 0.39% 26
2019
Q4
$7.81M Sell
53,551
-544
-1% -$73.8K 0.36% 29
2019
Q3
$7M Sell
54,095
-357
-0.7% -$47K 0.36% 28
2019
Q2
$7.58M Sell
54,452
-2,923
-5% -$405K 0.4% 25
2019
Q1
$8.02M Buy
57,375
+10,212
+22% +$1.37M 0.42% 25
2018
Q4
$6.09M Sell
47,163
-1,165
-2% -$163K 0.36% 25
2018
Q3
$6.68M Buy
48,328
+2,947
+6% +$392K 0.4% 20
2018
Q2
$5.51M Sell
45,381
-2,085
-4% -$260K 0.4% 21
2018
Q1
$6.08M Buy
47,466
+6,252
+15% +$845K 0.42% 24
2017
Q4
$5.76M Buy
41,214
+1,252
+3% +$174K 0.39% 24
2017
Q3
$5.2M Sell
39,962
-79
-0.2% -$10.5K 0.41% 22
2017
Q2
$5.3M Sell
40,041
-13,368
-25% -$1.71M 0.47% 21
2017
Q1
$6.65M Buy
53,409
+2,422
+5% +$289K 0.57% 20
2016
Q4
$5.87M Buy
50,987
+2,104
+4% +$243K 0.53% 21
2016
Q3
$5.78M Buy
48,883
+2,570
+6% +$312K 0.53% 19
2016
Q2
$5.62M Buy
46,313
+14,426
+45% +$1.64M 0.53% 18
2016
Q1
$3.45M Sell
31,887
-131
-0.4% -$13.6K 0.34% 24
2015
Q4
$3.29M Sell
32,018
-33
-0.1% -$3.32K 0.3% 31
2015
Q3
$2.99M Sell
32,051
-1,715
-5% -$166K 0.32% 28
2015
Q2
$3.29M Buy
33,766
+1,522
+5% +$152K 0.32% 30
2015
Q1
$3.24M Buy
32,244
+2,190
+7% +$223K 0.32% 29
2014
Q4
$3.14M Buy
30,054
+4,711
+19% +$496K 0.32% 35
2014
Q3
$2.7M Buy
25,343
+2,754
+12% +$286K 0.27% 32
2014
Q2
$2.36M Buy
22,589
+1,332
+6% +$135K 0.27% 32
2014
Q1
$2.09M Buy
21,257
+469
+2% +$43.5K 0.27% 34
2013
Q4
$1.9M Sell
20,788
-491
-2% -$45.3K 0.26% 34
2013
Q3
$1.84M Buy
21,279
+2,170
+11% +$195K 0.29% 30
2013
Q2
$1.64M Buy
+19,109
New +$1.62M 0.3% 31

Other funds holding JNJ

Homrich & Berg's JNJ Position: Q3 2021 in Review

Homrich & Berg reduced its Johnson & Johnson (JNJ) stake by 2.4% in Q3 2021, selling an estimated $332K and leaving 78,898 shares worth $12.7M. The position accounts for 0.29% of the portfolio, ranked #27.

Homrich & Berg first reported a position in JNJ in Q2 2013 and has held it in 34 quarters since. The position peaked at $13.3M in Q2 2021. 3,312 funds tracked by Wall St. Rank hold JNJ as of Q3 2021.

  • Homrich & Berg held 78,898 shares of Johnson & Johnson worth $12.7M as of Q3 2021.
  • Homrich & Berg sold 1,948 Johnson & Johnson shares in Q3 2021, an estimated $332K.
  • Johnson & Johnson made up 0.29% of Homrich & Berg's portfolio in Q3 2021, its #27 holding.
  • Homrich & Berg first reported a position in Johnson & Johnson in Q2 2013 and has held it in 34 quarters since.
  • Homrich & Berg's Johnson & Johnson position peaked at $13.3M in Q2 2021.
  • 3,312 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2021.

Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.